154
Views
22
CrossRef citations to date
0
Altmetric
Original Research

Toward antituberculosis drugs: in silico screening of synthetic compounds against Mycobacterium tuberculosisl,d-transpeptidase 2

, , , , , , & show all
Pages 1147-1157 | Published online: 11 Mar 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Manish Dwivedi, Sandra Jose, Megha Gupta, Sreevidya S. Devi, Ritu Raj & Dinesh Kumar. (2023) Copper transporter protein (MctB) as a therapeutic target to elicit antimycobacterial activity against tuberculosis. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-15.
Read now
Charlaine A Aventurado, Junie B Billones, Ross D Vasquez & Agnes L Castillo. (2020) In Ovo and In Silico Evaluation of the Anti-Angiogenic Potential of Syringin. Drug Design, Development and Therapy 14, pages 5189-5204.
Read now
Alexey Aleksandrov & Hannu Myllykallio. (2019) Advances and challenges in drug design against tuberculosis: application of in silico approaches. Expert Opinion on Drug Discovery 14:1, pages 35-46.
Read now
Junie B Billones, Maria Constancia O Carrillo, Voltaire G Organo, Jamie Bernadette A Sy, Nina Abigail B Clavio, Stephani Joy Y Macalino, Inno A Emnacen, Alexandra P Lee, Paul Kenny L Ko & Gisela P Concepcion. (2017) In silico discovery and in vitro activity of inhibitors against Mycobacterium tuberculosis 7,8-diaminopelargonic acid synthase (Mtb BioA). Drug Design, Development and Therapy 11, pages 563-574.
Read now

Articles from other publishers (18)

Shasank S. Swain, Sanghamitra Pati & Tahziba Hussain. (2022) Quinoline heterocyclic containing plant and marine candidates against drug-resistant Mycobacterium tuberculosis: A systematic drug-ability investigation. European Journal of Medicinal Chemistry 232, pages 114173.
Crossref
Jianying Han, Xueting Liu, Lixin Zhang, Ronald J. Quinn & Yunjiang Feng. (2022) Anti-mycobacterial natural products and mechanisms of action. Natural Product Reports 39:1, pages 77-89.
Crossref
Murtala A. Ejalonibu, Segun A. Ogundare, Ahmed A. Elrashedy, Morufat A. Ejalonibu, Monsurat M. Lawal, Ndumiso N. Mhlongo & Hezekiel M. Kumalo. (2021) Drug Discovery for Mycobacterium tuberculosis Using Structure-Based Computer-Aided Drug Design Approach. International Journal of Molecular Sciences 22:24, pages 13259.
Crossref
Junie B. Billones & Nina Abigail B. Clavio. (2021) <i>In Silico</i> Discovery of Natural Products Against Dengue RNA-Dependent RNA Polymerase Drug Target. Chem-Bio Informatics Journal 21:0, pages 11-27.
Crossref
Alexander D.H. Kingdon & Luke J. Alderwick. (2021) Structure-based in silico approaches for drug discovery against Mycobacterium tuberculosis. Computational and Structural Biotechnology Journal 19, pages 3708-3719.
Crossref
Kleber Santiago Freitas e Silva, Raisa Melo Lima, Patrícia de Sousa Lima, Lilian Cristiane Baeza, Roosevelt Alves da Silva, Célia Maria de Almeida Soares & Maristela Pereira. (2020) Interaction of Isocitrate Lyase with Proteins Involved in the Energetic Metabolism in Paracoccidioides lutzii. Journal of Fungi 6:4, pages 309.
Crossref
Gideon F. Tolufashe, Victor T. Sabe, Colins U. Ibeji, Thandokuhle Ntombela, Thavendran Govender, Glenn E.M. Maguire, Hendrik G. Kruger, Gyanu Lamichhane & Bahareh Honarparvar. (2020) Structure and Function of L,D- and D,D-Transpeptidase Family Enzymes from Mycobacterium tuberculosis. Current Medicinal Chemistry 27:19, pages 3250-3267.
Crossref
Stephen A. Cochrane & Christopher T. Lohans. (2020) Breaking down the cell wall: Strategies for antibiotic discovery targeting bacterial transpeptidases. European Journal of Medicinal Chemistry 194, pages 112262.
Crossref
Stephani Joy Y. Macalino, Junie B. Billones, Voltaire G. Organo & Maria Constancia O. Carrillo. (2020) In Silico Strategies in Tuberculosis Drug Discovery. Molecules 25:3, pages 665.
Crossref
Victor T. Sabe, Gideon F. Tolufashe, Collins U. Ibeji, Sibusiso B. Maseko, Thavendran Govender, Glenn E. M. Maguire, Gyanu Lamichhane, Bahareh Honarparvar & Hendrik G. Kruger. (2019) Identification of potent L,D-transpeptidase 5 inhibitors for Mycobacterium tuberculosis as potential anti-TB leads: virtual screening and molecular dynamics simulations. Journal of Molecular Modeling 25:11.
Crossref
Rahul Balasaheb Aher & Kunal Roy. (2019) Computational Approaches as Rational Decision Support Systems for Discovering Next-Generation Antitubercular Agents: Mini-Review. Current Computer-Aided Drug Design 15:5, pages 369-383.
Crossref
Giulia Oliveira Timo, Rodrigo Souza Silva Valle dos Reis, Adriana Françozo de Melo, Thales Viana Labourdette Costa, Pérola de Oliveira Magalhães & Mauricio Homem-de-Mello. (2019) Predictive Power of In Silico Approach to Evaluate Chemicals against M. tuberculosis: A Systematic Review. Pharmaceuticals 12:3, pages 135.
Crossref
Junie B. Billones & Marielle Alyanna T. Bangalan. (2019) Structure-Based Discovery of Inhibitors Against MurE in Methicillin-Resistant Staphylococcus Aureus. Oriental Journal of Chemistry 35:2, pages 618-625.
Crossref
Gideon F. Tolufashe, Amit K. Halder, Collins U. Ibeji, Monsurat M. Lawal, Thandokuhle Ntombela, Thavendran Govender, Glenn E. M. Maguire, Gyanu Lamichhane, Hendrik G. Kruger & Bahareh Honarparvar. (2018) Inhibition of Mycobacterium tuberculosis L,D‐Transpeptidase 5 by Carbapenems: MD and QM/MM Mechanistic Studies . ChemistrySelect 3:48, pages 13603-13612.
Crossref
PEÑAFRANCIA D. RARIZAJUNIE B. BILLONES. (2018) Retusenol Potentially Inhibits Putative Drug Targets for Tuberculosis, Cardiovascular Diseases, Cancer and HIV: (A Reverse Docking Study). Oriental Journal of Chemistry 34:4, pages 1795-1801.
Crossref
Mustafa Alhaji Isa, Rita Singh Majumdhar & Shazia Haider. (2018) In silico docking and molecular dynamics simulation of 3-dehydroquinate synthase (DHQS) from Mycobacterium tuberculosis. Journal of Molecular Modeling 24:6.
Crossref
Sakthivel Balasubramaniyan, Navabshan Irfan, Appavoo Umamaheswari & Ayarivan Puratchikody. (2018) Design and virtual screening of novel fluoroquinolone analogs as effective mutant DNA GyrA inhibitors against urinary tract infection-causing fluoroquinolone resistant Escherichia coli . RSC Advances 8:42, pages 23629-23647.
Crossref
Ming Li, Fang Wen, Shengguo Zhao, Pengpeng Wang, Songli Li, Yangdong Zhang, Nan Zheng & Jiaqi Wang. (2016) Exploring the Molecular Basis for Binding of Inhibitors by Threonyl-tRNA Synthetase from Brucella abortus: A Virtual Screening Study. International Journal of Molecular Sciences 17:7, pages 1078.
Crossref